![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, ti... Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator. Show more
Viking Therapeutics Presents Preclinical Data on Novel Dual Amylin and Calcitonin Receptor Agonists at 84th Scientific Sessions of the American Diabetes Association PR Newswire SAN DIEGO, June...
Viking Therapeutics Announces Positive 52-Week Histologic Data from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed Non-Alcoholic Steatohepatitis (NASH) PR Newswire SAN DIEGO...
Viking Therapeutics to Participate at Upcoming Investor Conferences PR Newswire SAN DIEGO, May 30, 2024 SAN DIEGO, May 30, 2024 /PRNewswire/ --ย Viking Therapeutics, Inc. ("Viking") (NASDAQ:...
Viking Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update PR Newswire SAN DIEGO, April 24, 2024 Conference call scheduled for 4:30 p.m. ET today Results From...
U.S. index futures are showing mixed results in pre-market trading this Wednesday, as investors assess the latest financial results released. As of 6:31 AM, Dow Jones Industrial Average futures...
Period โ | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.37 | 0.731080814068 | 50.61 | 54.4199 | 46.11 | 4157976 | 50.46181071 | CS |
4 | -12.91 | -20.2066051025 | 63.89 | 65.42 | 46.11 | 3750245 | 54.01362981 | CS |
12 | -28.02 | -35.4683544304 | 79 | 81.86 | 46.11 | 3167043 | 64.50262681 | CS |
26 | 31.67 | 164.008285862 | 19.31 | 99.3999 | 17.23 | 4796528 | 63.54069439 | CS |
52 | 33.26 | 187.69751693 | 17.72 | 99.3999 | 8.28 | 3523010 | 47.59552369 | CS |
156 | 44.23 | 655.259259259 | 6.75 | 99.3999 | 2.02 | 2378246 | 28.82815523 | CS |
260 | 43.01 | 539.64868256 | 7.97 | 99.3999 | 2.02 | 1942286 | 22.80086883 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions